|
시장보고서
상품코드
2055253
유전자 발현 시장 : 제품 유형별, 용도별, 기술별, 워크플로우 단계별, 샘플 유형별, 최종사용자별, 지역별Gene Expression Market, By Product Type, By Application, By Technology, By Workflow Stage, By Sample Type, By End User, By Geography |
||||||
유전자 발현 시장은 2026년 174억 5,000만 달러로 추정되고, 2033년에 252억 2,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR5.4%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 174억 5,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 5.40% | 2033년 시장 규모 예측 : | 252억 2,000만 달러 |
유전자 발현이란, DNA에 암호화된 유전 정보를 세포 활동을 주도하고 생물의 특성을 결정짓는 기능성 단백질로 변환하는 기본적인 생물학적 과정입니다. 전 세계 유전자 발현 시장은 다양한 생물학적 시스템에서 유전자 활성 패턴을 분석, 정량화 및 이해하기 위해 설계된 광범위한 기술, 시약, 장비 및 서비스를 포괄합니다. 이처럼 급속히 진화하는 시장에는 RNA 시퀀싱, 마이크로어레이, 정량 PCR, 차세대 시퀀싱 기술 등의 고급 분석 플랫폼이 포함되어 있어, 연구자들이 복잡한 유전자 조절 메커니즘을 규명할 수 있게 해줍니다.
이 시장은 기초 연구, 신약 및 의약품 개발, 맞춤형 의료, 농업 생명공학, 임상 진단에 이르는 다양한 용도에 대응하고 있습니다. 유전체 연구에 대한 투자 증가, 유전성 질환의 유병률 상승, 정밀 의학(Precision Medicine) 접근법에 대한 관심 고조와 함께, 유전자 발현 시장은 과학적 이해의 심화와 치료적 개입의 추진에 있어 매우 중요한 역할을 수행하고 있습니다. 인공지능(AI) 및 머신러닝 알고리즘과 유전자 발현 분석 플랫폼의 통합은 데이터 분석 능력에 획기적인 변화를 가져오고 있으며, 이를 통해 연구자들은 방대한 유전체 데이터 세트에서 의미 있는 인사이트를 도출하고 생명과학 분야의 획기적인 발견을 가속화할 수 있게 되었습니다.
시장 역학
세계 유전자 발현 시장은 분자생물학 연구와 임상 적용의 양상을 근본적으로 변화시키고 있는 몇 가지 주요 촉진요인에 의해 주도되고 있습니다. 전 세계 정부 기관과 민간 단체의 유전체 연구 자금 지원이 급격히 증가하면서, 연구자들은 첨단 유전자 발현 분석 기술에 투자하고 연구 역량을 확대할 수 있게 되었습니다. 암, 유전성 질환, 복합성 질환의 유병률 증가에 따라, 질환의 기전을 이해하고 표적 치료법을 개발하기 위해서는 종합적인 유전자 발현 프로파일링이 필수적이며, 이는 고급 분석 플랫폼에 대한 큰 수요를 이끌고 있습니다.
개인의 유전자 프로파일에 기반하여 치료 전략을 조정하는 맞춤형 의료 접근법의 확대는 임상 현장에서 정확한 유전자 발현 분석의 필요성을 크게 높이고 있습니다. 또한, 차세대 시퀀싱, RNA-seq 기법, 고성능 스크리닝 플랫폼 분야의 기술적 진보로 인해 분석 정확도가 향상되고 운영 비용이 절감됨에 따라, 연구 기관 및 의료시설에서 유전자 발현 분석을 더욱 쉽게 활용할 수 있게 되었습니다. 그러나 시장에는 뚜렷한 제약도 존재합니다. 그 중 하나는 첨단 유전자 발현 분석 장치에 대한 막대한 설비 투자가 필요하다는 점으로, 이로 인해 소규모 연구 기관이나 신흥 시장의 기관에서는 도입이 제한될 가능성이 있습니다. 또한, 데이터 분석의 복잡성과 전문적인 생물정보학 지식의 필요성은 충분한 기술 자원이나 숙련된 인력이 부족한 조직에게는 장벽이 됩니다.
또한, 규제 준수 요건 및 임상 적용에 따른 승인 절차의 장기화는 시장 진출기업 시장 진입 지연을 초래하고, 개발 비용을 증가시킬 가능성이 있습니다. 이러한 과제가 있는 반면, 농업 생명공학, 환경 모니터링, 산업 생명공학 분야에서의 유전자 발현 분석 활용이 확대됨에 따라 큰 기회가 생겨나고 있습니다. 인공지능(AI) 및 머신러닝 알고리즘의 통합이 진전됨에 따라, 복잡한 유전체 데이터 세트를 처리하고 연구자 및 임상의에게 실행 가능한 인사이트를 제공할 수 있는 보다 고도화된 분석 플랫폼을 개발할 기회가 생겨나고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 유전자 발현 시장의 주요 기업 프로파일을 작성하였습니다. 구체적으로는 기업의 주요 성과, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 전 세계 유전자 발현 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 유전자 발현 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 유전자 발현 시장 : 제품 유형별, 2021-2033년
제5장 세계의 유전자 발현 시장 : 용도별, 2021-2033년
제6장 세계의 유전자 발현 시장 : 기술별, 2021-2033년
제7장 세계의 유전자 발현 시장 : 워크플로우 단계별, 2021-2033년
제8장 세계의 유전자 발현 시장 : 샘플 유형별, 2021-2033년
제9장 세계의 유전자 발현 시장 : 최종사용자별, 2021-2033년
제10장 세계의 유전자 발현 시장 : 지역별, 2021-2033년
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고 문헌과 조사 방법
LSH 26.06.23Gene Expression Market is estimated to be valued at USD 17.45 Bn in 2026 and is expected to reach USD 25.22 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 17.45 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.40% | 2033 Value Projection: | USD 25.22 Bn |
Gene expression represents a fundamental biological process through which genetic information encoded in DNA is converted into functional proteins that drive cellular activities and determine organism characteristics. The global gene expression market encompasses a comprehensive range of technologies, reagents, instruments, and services designed to analyze, quantify, and understand gene activity patterns across various biological systems. This rapidly evolving market includes sophisticated analytical platforms such as RNA sequencing, microarrays, quantitative PCR, and next-generation sequencing technologies that enable researchers to decode complex gene regulatory mechanisms.
The market serves diverse applications spanning basic research, drug discovery and development, personalized medicine, agricultural biotechnology, and clinical diagnostics. With increasing investments in genomics research, rising prevalence of genetic disorders, and growing emphasis on precision medicine approaches, the gene expression market has become pivotal in advancing scientific understanding and therapeutic interventions. The integration of artificial intelligence and machine learning algorithms with gene expression analysis platforms is further revolutionizing data interpretation capabilities, enabling researchers to extract meaningful insights from vast genomic datasets and accelerate breakthrough discoveries in life sciences.
Market Dynamics
The global gene expression market is propelled by several key drivers that are fundamentally reshaping the landscape of molecular biology research and clinical applications. The exponential growth in genomics research funding from government agencies and private organizations worldwide serves as a primary catalyst, enabling researchers to invest in advanced gene expression analysis technologies and expand their investigative capabilities. The increasing prevalence of cancer, genetic disorders, and complex diseases necessitates comprehensive gene expression profiling to understand disease mechanisms and develop targeted therapeutic interventions, driving substantial demand for sophisticated analytical platforms.
The rising adoption of personalized medicine approaches, where treatment strategies are tailored based on individual genetic profiles, significantly amplifies the need for accurate gene expression analysis in clinical settings. Additionally, technological advancements in next-generation sequencing, RNA-seq methodologies, and high-throughput screening platforms are enhancing analytical precision and reducing operational costs, making gene expression analysis more accessible to research institutions and healthcare facilities. However, the market faces notable restraints including the high capital investment requirements for advanced gene expression analysis equipment, which can limit adoption among smaller research organizations and emerging market institutions. The complexity of data interpretation and the need for specialized bioinformatics expertise create barriers for organizations lacking adequate technical resources and skilled personnel.
Regulatory compliance requirements and lengthy approval processes for clinical applications can delay market penetration and increase development costs for market participants. Despite these challenges, significant opportunities emerge from the expanding applications of gene expression analysis in agricultural biotechnology, environmental monitoring, and industrial biotechnology sectors. The growing integration of artificial intelligence and machine learning algorithms presents opportunities to develop more sophisticated analytical platforms capable of processing complex genomic datasets and providing actionable insights for researchers and clinicians.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global gene expression market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc, Agilent Technologies Inc, Illumina Inc, QIAGEN N.V, Bio-Rad Laboratories Inc, Roche Diagnostics, PerkinElmer Inc, Takara Bio Inc, Promega Corporation, GE Healthcare, Pacific Biosciences of California Inc, Oxford Nanopore Technologies, Fluidigm Corporation, Lonza Group Ltd, and Eurofins Genomics
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global gene expression market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gene expression market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Instruments (PCR Systems, Next-Generation Sequencing Systems, Microarray Scanners, etc.)
- Consumables and Reagents (Kits, Assays and Probes, DNA Chips etc.)
- Software and Services
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Drug Discovery and Development
- Clinical Diagnostics
- Research and Development
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- DNA Microarray
- PCR-Based (qPCR, RT-PCR)
- RNA Sequencing (RNA-Seq)
- Northern Blotting
- Next-Generation Sequencing (NGS)
- Serial Analysis of Gene Expression (SAGE)
- Workflow Stage Insights (Revenue, USD Bn, 2021 - 2033)
- Sample Collection and Preparation
- RNA Isolation and Purification
- cDNA Synthesis and Amplification
- Detection and Quantification
- Data Analysis and Interpretation
- Sample Type Insights (Revenue, USD Bn, 2021 - 2033)
- Human Samples
- Animal Samples
- Microbial Samples
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Hospitals and Clinical Laboratories
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific Inc
- Agilent Technologies Inc
- Illumina Inc
- QIAGEN N.V
- Bio-Rad Laboratories Inc
- Roche Diagnostics
- PerkinElmer Inc
- Takara Bio Inc
- Promega Corporation
- GE Healthcare
- Pacific Biosciences of California Inc
- Oxford Nanopore Technologies
- Fluidigm Corporation
- Lonza Group Ltd
- Eurofins Genomics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Gene Expression Market, By Product Type
- Global Gene Expression Market, By Application
- Global Gene Expression Market, By Technology
- Global Gene Expression Market, By Workflow Stage
- Global Gene Expression Market, By Sample Type
- Global Gene Expression Market, By End User
- Global Gene Expression Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Gene Expression Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Instruments (PCR Systems, Next-Generation Sequencing Systems, Microarray Scanners, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Consumables and Reagents (Kits, Assays and Probes, DNA Chips, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Gene Expression Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Gene Expression Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- DNA Microarray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- PCR-Based (qPCR, RT-PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- RNA Sequencing (RNA-Seq)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Northern Blotting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Serial Analysis of Gene Expression (SAGE)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Gene Expression Market, By Workflow Stage, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Sample Collection and Preparation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- RNA Isolation and Purification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- cDNA Synthesis and Amplification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Detection and Quantification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Data Analysis and Interpretation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Gene Expression Market, By Sample Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Human Samples
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Animal Samples
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Microbial Samples
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Gene Expression Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hospitals and Clinical Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Gene Expression Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive landscape
- Thermo Fisher Scientific Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN N.V
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takara Bio Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Promega Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pacific Biosciences of California Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Oxford Nanopore Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fluidigm Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eurofins Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
